Liposomal Bupivacaine (Exparel) in Sarcomas

Clinical trial NCT03867188 · TERMINATED

Trial details

NCT number: NCT03867188
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Soft Tissue Tumor Soft Tissue Tumor and/or Sarcoma

Start date: 2019-01-14
Primary completion: 2019-06-11
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.